Cronos Group Inc vs MKS Instruments — how do they compare? Cronos Group Inc trades at $3.24 (market cap $1.18B), while MKS Instruments trades at $265 (market cap $17.61B). The key difference: MKS Instruments is far larger — about 14.9× Cronos Group Inc's market cap, and MKS Instruments pays a 0.38% dividend while Cronos Group Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Cronos Group Inc for 22 Days and MKS Instruments for 7 Days on average.
| CRON | MKSI | |
|---|---|---|
Market Cap | $1.18B | $17.61B |
Volume | 968,037 | 1,275,355 |
Sector | Health | Technology |
52-Week High | $3.55 | $444.80 |
52-Week Low | $2.30 | $121.26 |
Typical Hold Time | 22 Days | 7 Days |
Enterprise Value | $387.62M | $21.18B |
Dividend Yield | — | 0.38% |
Signals from Pluang's Aura AI — not financial advice
CRON trades at $3.24, down 1.37% on the day, with a bearish technical signal and neutral oscillators. The company reported a net loss of $9.45M in 2025 despite revenue growth to $146.59M, but recent quarters show earnings beats. Analyst sentiment is mixed with 20% buy, 60% hold, and 20% sell ratings. Recent news highlights investor day events and international expansion efforts.
The outlook is cautious; profitability improvements and cash flow generation are key catalysts, but high valuation multiples and negative net cash flow pose risks. Regulatory developments in cannabis markets and execution on growth targets will be critical for stock performance.
No Aura AI signal available yet.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
Cronos Group, headquartered in Toronto, Canada cultivates and sells medicinal and recreational cannabis through its medicinal brand, Peace Naturals, and its two recreational brands, Cove and Spinach. Although it primarily operates in Canada, Cronos exports medical cannabis to Poland and Germany. In addition, it has entered joint ventures in Israel, Colombia, and Australia to drive further international cultivation and distribution growth. In the U.S. the company directly sells hemp-derived CBD and has an option to acquire 10.5% of U.S. multistate operator PharmaCann.
Read more on CRON →MKS develops instruments, systems, and process control solutions for advanced manufacturing. Its technologies serve semiconductor manufacturing, electronics and packaging, photonics, and specialty industrial applications.
Read more on MKSI →